|
US 12,084,522 B2 |
|
| Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Colette Song, Ostfildern (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); and Harpreet Singh, Munich (DE) |
| Assigned to Immatics Biotechnologies GmbH, (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Jun. 4, 2021, as Appl. No. 17/339,157. |
| Application 17/339,157 is a continuation of application No. 16/457,012, filed on Jun. 28, 2019, abandoned. |
| Application 16/457,012 is a continuation of application No. 15/445,461, filed on Feb. 28, 2017, granted, now 10,400,011, issued on Sep. 3, 2019. |
| Claims priority of provisional application 62/302,010, filed on Mar. 1, 2016. |
| Claims priority of application No. 1603568 (GB), filed on Mar. 1, 2016. |
| Prior Publication US 2021/0292367 A1, Sep. 23, 2021 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 16/18 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/725 (2006.01); C12N 15/115 (2010.01); G01N 33/68 (2006.01); A61K 35/12 (2015.01) |